News | Latest Breaking News Stories & Headlines | RTÉ

Weather Warning

Sanofi and GSK have started a clinical trial of their protein-based coronavirus vaccine candidate

Sanofi sees coronavirus vaccine priced below €10

Business • 07 Sep

Sales of GSK's shingles vaccine fell and stockpiling of pain and lung medication tapered as countries eased lockdowns

GSK's quarterly profit misses as stockpiling eases

Business • 29 Jul

The Sanofi/GSK vaccine combines Sanofi's S-protein Covid-19 antigen and GSK's pandemic adjuvant technology

UK secures 60 million doses of Sanofi/GSK vaccine

Business • 29 Jul

Sanofi expects to get approval for the potential Covid-19 vaccine it is developing with GlaxoSmithKline by the first half of next year

Sanofi eyes approval of Covid-19 vaccine by H1 2021

Business • 23 Jun

GSK is one of several companies in the race to develop a vaccine for Covid-19

GSK to make 1 billion doses of virus vaccine booster

Business • 28 May

GlaxoSmithKline's CEO Emma Walmsley

GSK does not see mass-produced vaccine before mid-2021

Business • 29 Apr

Purdue Pharma has agreed tentative multibillion-dollar deal with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the US opioid crisis

Purdue deal to rank among biggest in pharma history

Business • 16 Sep 19

The ownership of GsK's Cork manufacturing site - all facilities, business operations and employees - will transfer to Thermo Fisher

Thermo Fisher buys GsK's Cork facility for €90m

Business • 16 May 19

GSK's chief executive Emma Walmsley

GSK expects shingles drug sales to exceed $1.3 billion

Business • 01 May 19

Emma Walmsley, the chief executive of GlaxoSmithKline

GSK and Pfizer to combine consumer health businesses

Business • 19 Dec 18

GSK CEO Emma Walmsley said today's deal will accelerate efforts to improve its performance

GSK buys Novartis stake in consumer healthcare venture

Business • 27 Mar 18

GSK was seen as the front runner to buy the assets from Pfizer

GSK pulls out of $20 billion race for Pfizer asset

Business • 23 Mar 18

Incoming GlaxoSmithKline chief executive Emma Walmsley

GSK's new CEO to get 25% less after pay policy review

Business • 15 Mar 17

GlaxoSmithKline generates more than 95% of its sales outside Britain

GlaxoSmithKline sees big windfall as pound slides

Business • 26 Oct 16

Emma Walmsley named as drugmaker's new chief executive

GlaxoSmithKline names Walmsley as new CEO

Business • 20 Sep 16

GSK's sales, in sterling terms, rose 2% to £6.29 billion in the three months to the end of December

New drugs help GSK offset drag of Advair sales

Business • 03 Feb 16

GSK sold its oncology business to Novartis for $16bn

GSK sees quarterly profit soar after Novartis deal

Business • 06 May 15

GlaxoSmithKline plans to buy Novartis's global human vaccines business and tie up the two firms' consumer health businesses

EU gives conditional backing to Novartis, GSK deal

Business • 28 Jan 15

GlaxoSmithKline drops 'established products' sale plans

GSK drops plan to sell off older drugs business

Business • 05 Dec 14

The Federal Trade Commission clears Medtronic's $42.9 billion deal to buy Dublin-based Covidien

Medtronic gets US clearance to buy Covidien

Business • 27 Nov 14

The World Health Organisation has said there has been almost 16,000 cases of Ebola in west Africa

Ebola vaccine passes early safety test

News • 27 Nov 14

GSK planned to cut costs by £1bn per year by 2016

GSK to float HIV drug arm as part of recovery plan

Business • 22 Oct 14

Philip Hampton has been chairman of Royal Bank of Scotland since 2009

RBS chairman to leave for GlaxoSmithKline

Business • 25 Sep 14

GlaxoSmithKline fined 3 billion yuan by Chinese authorities

China fines UK drugmaker GSK $489m

Business • 19 Sep 14

GlaxoSmithKline is being investigated by Chinese authorities

Investigator hired by GSK to face trial in China

Business • 14 Jul 14

Showing 1 - 25 of 44 stories